p38 MAPK and MMP-9 cooperatively regulate mucus overproduction in mice exposed to acrolein fog

International Immunopharmacology

Volumn 9, Issue 10, 2009, Pages 1228-1235

  Liu, Dai Shun ^a   Wang, Tao ^a   Han, Su Xia ^a   Dong, Jia Jia ^a   Liao, Zeng Lin ^a   He, Guang Ming ^a   Chen, Lei ^a   Chen, Ya Juan ^a   Xu, Dan ^a   Hou, Yan ^a   Li, Yan Ping ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acrolein; Airway mucus production; MMP 9; p38 MAPK; SB203580

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACROLEIN; GELATIN; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MUCIN; MUCIN 5AC;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GOBLET CELL; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; MOUSE; MUCUS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ACROLEIN; ANIMALS; CELLS, CULTURED; CYTOKINES; IMIDAZOLES; LUNG; MALE; MATRIX METALLOPROTEINASE 9; MICE; MUCIN 5AC; MUCUS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTOR CROSS-TALK; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY MUCOSA;

EID: 68949175351     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.07.005     Document Type: Article

References (32)

1. Rennard S.I. Looking at the patient-approaching the problem of COPD. N Engl J Med 350 (2004) 965-966
2. Rose M.C., and Voynow J.A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev 86 (2006) 245-278
3. Kehrer J.P., and Biswal S.S. The molecular effects of acrolein. Toxicol Sci 57 (2000) 6-15
4. Borchers M.T., Wesselkamper S., Wert S.E., Shapiro S.D., and Leikauf G.D. Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am J Physiol 277 (1999) L489-L497
5. Borchers M.T., Wesselkamper S.C., Harris N.L., Deshmukh H., Beckman E., Vitucci M., et al. CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp Mol Pathol 83 (2007) 301-310
6. Wang T., Liu Y., Chen L., Wang X., Hu X.R., Feng Y.L., et al. Effect of sildenafil on acrolein-induced airway inflammation and mucus production in rats. Eur Respir J 33 (2009) 1122-1132
7. Renda T., Baraldo S., Pelaia G., Bazzan E., Turato G., Papi A., et al. Increased activation of p38 MAPK in COPD. Eur Respir J 31 (2008) 62-69
8. Fitzgerald M.F., and Fox J.C. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Drug Discov Today 12 (2007) 479-486
9. Liu W., Liang Q., Balzar S., Wenzel S., Gorska M., and Alam R. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J Allergy Clin Immunol 121 (2008) 893-902.e2
10. Moretto N., Facchinetti F., Southworth T., Civelli M., Singh D., and Patacchini R. {alpha},{beta}-unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol 296 (2009) L839-L848
11. Marwick J.A., Kirkham P.A., Stevenson C.S., Danahay H., Giddings J., Butler K., et al. Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am J Respir Cell Mol Biol 31 (2004) 633-642
12. Kim H.J., Lee H.S., Chong Y.H., and Kang J.L. p38 mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225 (2006) 36-47
13. Smith S.J., Fenwick P.S., Nicholson A.G., Kirschenbaum F., Finney-Hayward T.K., Higgins L.S., et al. Inhibitory effect of p38 mitogen-activated protein kinase inhibitors on cytokine release from human macrophages. Br J Pharmacol 149 (2006) 393-404
14. Komatsu K., Jono H., Lim J.H., Imasato A., Xu H., Kai H., et al. Glucocorticoids inhibit nontypeable Haemophilus influenzae-induced Muc5ac mucin expression via MAPK phosphatase-1-dependent inhibition of p38 MAPK. Biochem Biophys Res Commun 377 (2008) 763-768
15. Burgel P.R., and Nadel J.A. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59 (2004) 992-996
16. Deshmukh H.S., Case L.M., Wesselkamper S.C., Borchers M.T., Martin L.D., Shertzer H.G., et al. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am J Respir Crit Care Med 171 (2005) 305-314
17. Nash S.P., and Heuertz R.M. Blockade of p38 MAP kinase inhibits complement-induced acute lung injury in a murine model. Int Immunopharmacol 5 (2005) 1870-1880
18. Deshmukh H.S., Shaver C., Case L.M., Dietsch M., Wesselkamper S.C., Hardie W.D., et al. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol 38 (2008) 446-454
19. Nguyen J., Gogusev J., Knapnougel P., and Bauvois B. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes. Immunol Lett 106 (2006) 34-41
20. Wiehler S., Cuvelier S.L., Chakrabarti S., and Patel K.D. p38 MAP kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochem Biophys Res Commun 315 (2004) 463-470
21. Underwood D.C., Osborn R.R., Bochnowicz S., Webb E.F., Rieman D.J., Lee J.C., et al. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 279 (2000) L895-902
22. Wang X., Li J.Q., Chen L., Wang H.X., Sun B.B., Wang T., et al. Effects of phosphodiesterase-4 inhibitor on the mucin secretion in airway stimulated with acrolein: experiment with rats. Zhonghua Yi Xue Za Zhi 88 (2008) 2988-2993
23. Suga M., Iyonaga K., Okamoto T., Gushima Y., Miyakawa H., Akaike T., et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med 162 (2000) 1949-1956
24. Park Y.S., Kim J., Misonou Y., Takamiya R., Takahashi M., Freeman M.R., et al. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler Thromb Vasc Biol 27 (2007) 1319-1325
25. Medicherla S., Fitzgerald M.F., Spicer D., Woodman P., Ma J.Y., Kapoun A.M., et al. p38alpha-selective mitogen-activated protein kinase inhibitor SD-282 reduces inflammation in a subchronic model of tobacco smoke-induced airway inflammation. J Pharmacol Exp Ther 324 (2008) 921-929
26. Arcaroli J., Yum H.K., Kupfner J., Park J.S., Yang K.Y., and Abraham E. Role of p38 MAP kinase in the development of acute lung injury. Clin Immunol 101 (2001) 211-219
27. Eckert R.E., Sharief Y., and Jones S.L. p38 mitogen-activated kinase (MAPK) is essential for equine neutrophil migration. Vet Immunol Immunopathol 129 (2009) 181-191
28. Chakrabarti S., Zee J.M., and Patel K.D. Regulation of matrix metalloproteinase-9 (MMP-9) in TNF-stimulated neutrophils: novel pathways for tertiary granule release. J Leukoc Biol 79 (2006) 214-222
29. Cho A., Graves J., and Reidy M.A. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 20 (2000) 2527-2532
30. Wang Y., Shen Y., Li K., Zhang P., Wang G., Gao L., et al. Role of matrix metalloproteinase-9 in lipopolysaccharide-induced mucin production in human airway epithelial cells. Arch Biochem Biophys 486 (2009) 111-118
31. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., et al. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res 271 (2001) 344-355
32. Nath P., Leung S.Y., Williams A., Noble A., Chakravarty S.D., Luedtke G.R., et al. Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness. Eur J Pharmacol 544 (2006) 160-167